Company Filing History:
6 out of 6 
2 out of 2 Years Active: 2015-2020
Title: Joseph M Fayad: Innovator in Hepatic Health Solutions
Introduction
Joseph M Fayad is a prominent inventor based in Las Vegas, NV (US), known for his significant contributions to the field of hepatic health. With a total of 7 patents, Fayad has focused on developing innovative diagnostics and treatment methods for liver-related conditions, particularly non-alcoholic hepatic steatosis and steatohepatitis.
Latest Patents
Fayad's latest patents include groundbreaking work on diagnostics and methods for the treatment of non-alcoholic hepatic steatosis and hepatic steatohepatitis. His inventions aim to characterize NASH through a combination of modeling and biomarkers, which enable the development of pharmaceutical compositions and treatment methods. These innovations address the inhibition, resolution, and prevention of Non-Alcoholic Fatty Liver Disease (NAFLD) and its complications. Fayad's work also extends to treating patients with hepatitis viral infections, including Hepatitis B and C, and the associated complications such as cirrhosis and hepatocellular cancer.
Career Highlights
Throughout his career, Joseph M Fayad has worked with notable companies, including Volant Holdings GmbH and Therabrake, Inc. His expertise in hepatic health has positioned him as a key figure in the development of therapeutic solutions for metabolic syndromes and liver diseases.
Collaborations
Fayad has collaborated with esteemed professionals in his field, including Jerome J Schentag and Scott V Monte. These partnerships have further enhanced his research and development efforts in hepatic health.
Conclusion
Joseph M Fayad's innovative work in the field of hepatic health has made a significant impact on the treatment and understanding of liver-related diseases. His contributions continue to pave the way for advancements in medical science and patient care.